scholarly journals Ipragliflozin, a sodium–glucose cotransporter 2 inhibitor, reduces bodyweight and fat mass, but not muscle mass, in Japanese type 2 diabetes patients treated with insulin: A randomized clinical trial

2019 ◽  
Vol 10 (4) ◽  
pp. 1012-1021 ◽  
Author(s):  
Hideka Inoue ◽  
Katsutaro Morino ◽  
Satoshi Ugi ◽  
Sachiko Tanaka‐Mizuno ◽  
Keiko Fuse ◽  
...  
2018 ◽  
Vol 12 (5) ◽  
pp. 617-624 ◽  
Author(s):  
Nazarii Kobyliak ◽  
Tetyana Falalyeyeva ◽  
Galyna Mykhalchyshyn ◽  
Dmytro Kyriienko ◽  
Iuliia Komissarenko

2011 ◽  
Vol 109 (6) ◽  
pp. 481-485 ◽  
Author(s):  
Mads Nybo ◽  
Simone Rørdam Preil ◽  
Henning Friis Juhl ◽  
Malene Olesen ◽  
Knud Yderstraede ◽  
...  

2012 ◽  
Vol 45 (04) ◽  
pp. 319-325 ◽  
Author(s):  
A. Esteghamati ◽  
M. Mousavizadeh ◽  
S. Noshad ◽  
A. Zandieh ◽  
H. Zarei ◽  
...  

10.19082/7155 ◽  
2018 ◽  
Vol 10 (8) ◽  
pp. 7155-7163
Author(s):  
Asieh Zarvasi ◽  
Ali Ansari Jaberi ◽  
Tayebeh Negahban Bonabi ◽  
Mahnaz Tashakori

Sign in / Sign up

Export Citation Format

Share Document